Agios Pharmaceuticals, Inc.

349 articles about Agios Pharmaceuticals, Inc.

• Shanghai ChemPartner Co., Ltd. and Agios Pharmaceuticals Expand Integrated Drug Discovery Research Collaboration

  7/9/2009

• Agios Pharmaceuticals' Focus of Drug Research – Cancer Metabolism – Selected for Stand Up To Cancer Grant

  5/28/2009

• Agios Pharmaceuticals Appoints David Schenkein, M.D. as CEO

  5/27/2009

• Agios Pharmaceuticals' Founders Author Science Review on Cancer Metabolism

  5/21/2009

• Agios Pharmaceuticals Highlights Extensive Cancer Metabolism Research at American Association for Cancer Research

  4/30/2009

• Agios Pharmaceuticals Appoints Charles Sawyers, M.D., to Scientific Advisory Board

  2/6/2009

• Agios Pharmaceuticals Expands Into 21,000 SqFt Facility

  11/24/2008

• Agios Pharmaceuticals Attracts Leading Cancer Metabolism Experts to Advisory Team

  11/24/2008

• Agios Pharmaceuticals Closes $33 Million Series A Funding

  7/7/2008